Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes
Year: 2021
Type: article
Source: AIDS
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: weight gain, tenofovir alafenamide, tenofovir disoproxil fumarate, integrase strand transfer inhibitors, dolutegravir, efavirenz, HIV, type 2 diabetes, cardiovascular disease, obesity, cardiovascular risk prediction, diabetes risk prediction, ADVANCE trial, Black African population, antiretroviral-naive patients
Open Access status: closed
OpenAlex ID: W3158467183
